Laidlaw Wealth Management LLC Sells 136 Shares of JPMorgan Chase & Co. (NYSE:JPM)

Laidlaw Wealth Management LLC lessened its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 4.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,893 shares of the financial services provider’s stock after selling 136 shares during the quarter. Laidlaw Wealth Management LLC’s holdings in JPMorgan Chase & Co. were worth $693,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of JPM. Cannon Financial Strategists Inc. boosted its position in shares of JPMorgan Chase & Co. by 6.7% in the 4th quarter. Cannon Financial Strategists Inc. now owns 1,542 shares of the financial services provider’s stock worth $370,000 after purchasing an additional 97 shares during the last quarter. Joel Adams & Associates Inc. bought a new position in JPMorgan Chase & Co. during the fourth quarter worth about $471,000. Global Retirement Partners LLC grew its position in shares of JPMorgan Chase & Co. by 23.0% during the 4th quarter. Global Retirement Partners LLC now owns 88,252 shares of the financial services provider’s stock worth $21,155,000 after buying an additional 16,485 shares during the period. Plan Group Financial LLC increased its stake in shares of JPMorgan Chase & Co. by 4.0% in the 4th quarter. Plan Group Financial LLC now owns 1,947 shares of the financial services provider’s stock valued at $467,000 after acquiring an additional 74 shares during the last quarter. Finally, Atlas Legacy Advisors LLC acquired a new stake in shares of JPMorgan Chase & Co. in the 4th quarter valued at approximately $3,882,000. Institutional investors and hedge funds own 71.55% of the company’s stock.

JPMorgan Chase & Co. Stock Up 2.1 %

Shares of JPM stock opened at $264.56 on Friday. The firm’s fifty day moving average price is $258.55 and its two-hundred day moving average price is $236.93. The company has a current ratio of 0.88, a quick ratio of 0.89 and a debt-to-equity ratio of 1.24. JPMorgan Chase & Co. has a 1 year low of $179.20 and a 1 year high of $280.25. The firm has a market capitalization of $739.74 billion, a P/E ratio of 13.40, a PEG ratio of 2.83 and a beta of 1.12.

JPMorgan Chase & Co. (NYSE:JPM) last released its earnings results on Wednesday, January 15th. The financial services provider reported $4.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.03 by $0.78. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The business had revenue of $42.77 billion for the quarter, compared to the consensus estimate of $41.90 billion. During the same quarter in the previous year, the business earned $3.04 earnings per share. JPMorgan Chase & Co.’s quarterly revenue was up 10.9% on a year-over-year basis. On average, equities analysts predict that JPMorgan Chase & Co. will post 18.1 EPS for the current fiscal year.

JPMorgan Chase & Co. Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.89%. The ex-dividend date of this dividend was Monday, January 6th. JPMorgan Chase & Co.’s payout ratio is presently 25.33%.

Analyst Upgrades and Downgrades

JPM has been the subject of several recent analyst reports. Truist Financial upped their target price on shares of JPMorgan Chase & Co. from $260.00 to $268.00 and gave the company a “hold” rating in a research note on Thursday, January 16th. Robert W. Baird cut shares of JPMorgan Chase & Co. from a “neutral” rating to an “underperform” rating and set a $200.00 price objective for the company. in a research report on Thursday, November 7th. Barclays lifted their target price on JPMorgan Chase & Co. from $304.00 to $330.00 and gave the stock an “overweight” rating in a report on Thursday, January 16th. Wolfe Research raised JPMorgan Chase & Co. from a “peer perform” rating to an “outperform” rating and set a $269.00 target price for the company in a research note on Friday, January 3rd. Finally, Keefe, Bruyette & Woods raised their price target on JPMorgan Chase & Co. from $257.00 to $264.00 and gave the stock a “market perform” rating in a research report on Thursday, January 16th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $251.78.

Insider Activity

In other news, CEO Troy L. Rohrbaugh sold 37,500 shares of JPMorgan Chase & Co. stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $269.84, for a total value of $10,119,000.00. Following the completion of the transaction, the chief executive officer now owns 158,381 shares of the company’s stock, valued at $42,737,529.04. This trade represents a 19.14 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, General Counsel Stacey Friedman sold 3,303 shares of the company’s stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $253.94, for a total transaction of $838,763.82. Following the completion of the sale, the general counsel now directly owns 47,620 shares in the company, valued at approximately $12,092,622.80. The trade was a 6.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 46,326 shares of company stock valued at $12,448,445. 0.79% of the stock is owned by insiders.

JPMorgan Chase & Co. Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.